Kura Oncology
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $20,874 | $18,265 | $17,336 | $20,750 |
Gross Profit | 20,631 | 17,648 | 17,336 | 17,538 |
EBITDA | -65,612 | -72,634 | -80,179 | -73,952 |
EBIT | -67,977 | -72,989 | -80,582 | -74,116 |
Net Income | -68,327 | -73,333 | -80,999 | -74,116 |
Net Change In Cash | 20,874 | 18,265 | 17,336 | 20,750 |
Free Cash Flow | -63,205 | -85,982 | 114,952 | -83,193 |
Cash | 70,242 | 39,083 | 149,099 | 95,287 |
Basic Shares | 88,855 | 88,610 | 88,050 | 87,645 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $67,482 | $53,883 | $0 | $0 |
Gross Profit | 67,425 | 53,883 | -849 | -759 |
EBITDA | -275,825 | -169,498 | -150,233 | -134,852 |
EBIT | -276,857 | -170,346 | -151,082 | -135,611 |
Net Income | -278,666 | -173,983 | -152,631 | -135,840 |
Net Change In Cash | 67,482 | 53,883 | 0 | 0 |
Cost of Revenue | -38,870 | |||
Free Cash Flow | -70,696 | 133,845 | -124,992 | -110,688 |
Cash | 149,099 | 224,462 | 37,318 | 51,802 |
Basic Shares | 87,676 | 86,161 | 73,229 | 66,990 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.77 |
2026-03-31 | -$0.82 |
2025-12-31 | -$0.92 |
2025-09-30 | -$0.85 |